Related Experiment Videos
A new autoantibody in celiac disease
Wulf B Storch1, Ulrike Schloeder
1Medical Faculty of the University of Heidelberg, Germany.
Clinical Laboratory
|February 9, 2002
Summary
A novel IgA autoantibody associated with therapy-resistant celiac disease was identified. This autoantibody differs from existing markers and may be mistaken for tissue transglutaminase antibodies.
Area of Science:
- Immunology
- Gastroenterology
- Autoantibody Research
Background:
- Celiac disease, also known as sprue, is an autoimmune disorder.
- Therapy-resistant cases present diagnostic challenges.
- Conventional diagnostic markers include antibodies against type 3 connective tissue and tissue transglutaminase.
Observation:
- A new IgA autoantibody was detected in a patient with therapy-resistant celiac disease.
- Immunofluorescence revealed distinct reactivity patterns compared to known autoantibodies.
- The antibody primarily targets the muscularis and muscularis mucosae of monkey esophagus.
Findings:
- The novel autoantibody exhibits a punctiform, not retiform, reaction pattern.
- It does not react with typical sites for anti-endomysium antibodies.
- At low magnification, it can be confused with tissue transglutaminase antibodies on esophageal sections.
Implications:
- This discovery may lead to new diagnostic tools for celiac disease.
- Further research is needed to identify the specific antigen targeted by this new autoantibody.
- Distinguishing this antibody is crucial for accurate diagnosis and patient management.